Netherlands· NL-8c92d03fa2a6
Colistimethaatnatrium Accord 2 miljoen IE, poeder voor oplossing voor injectie/infusie
A colistin product containing colistimethaat natrium (component a en b) + colistimethaat natrium (component a en b), registered in Netherlands by Accord Healthcare B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Colistin is registered in 11 of 19 countries.
Countries holding a registration under ATC J01XB01 (colistin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Colistin · ATC J01XB01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- COLISTIMETHAAT NATRIUM (Component A en B) + COLISTIMETHAAT NATRIUM (Component A en B)
- Manufacturer
- Accord Healthcare B.V.
- Country
- Netherlands (NL)
- ATC code
- J01XB01
- ATC class
- Colistin
- Defined daily dose
- 3 MIO, E
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id128745
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J01XB01
Colistin, as other registers publish it.
- SwitzerlandColiFin Pari
- SwitzerlandColiFin Pari
- SwitzerlandColiFin PARI 1 Mio. U.I., Pulver zur Herstellung einer Lösung für einen VerneblerPARI Swiss AG
- NetherlandsColiFin PARI 1.000.000 IE, poeder voor verneveloplossingPARI PHARMA GmbH
- SwitzerlandColiFin PARI 2 Mio. U.I., Pulver zur Herstellung einer Lösung für einen VerneblerPARI Swiss AG
- NetherlandsColiFin PARI 2.000.000 IE, poeder voor verneveloplossingPARI PHARMA GmbH
- FinlandColimycinOrion Corporation Orion Pharma
- FinlandColinebTeva B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/faf0f1b8-ee23-49a3-b713-1398ef8393a1 GET /v1/drugs/faf0f1b8-ee23-49a3-b713-1398ef8393a1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder voor oplossing voor injectie of infusie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h128745_smpc.pdf",
"strength": null,
"atc_label": "Colistin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg128745",
"excipients": [
"STIKSTOF (HEAD SPACE) (E 941)"
],
"substances": [
"COLISTIMETHAAT NATRIUM (Component A en B)",
"COLISTIMETHAAT NATRIUM (Component A en B)"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h128745.pdf",
"authorised_at": "2024/05/17",
"procedure_number": "NL/H/5448/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "128745",
"additional_monitoring": "N"
}See everything about colistin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.